Hsinchu, Taiwan

Ya-Ling Chiu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ya-Ling Chiu

Introduction

Ya-Ling Chiu is a prominent inventor based in Hsinchu, Taiwan. She has made significant contributions to the field of drug delivery systems and nucleic acid therapies. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Ya-Ling Chiu's latest patents include innovative technologies that enhance drug delivery and therapeutic efficacy. One of her notable inventions is a nucleic acid-drug complex, which comprises a nucleic acid sequence of an anti-PD-L1 aptamer and a CpG oligonucleotide sequence capable of activating TLR9. This complex is designed to improve the effectiveness of cancer therapies. Another significant patent is for hydrogel compositions and drug delivery systems that utilize polyglutamic acid (PGA) and polyethylene glycol (PEG). This hydrogel composition is engineered to maintain a pH value ranging from 4.0 to 6.5, providing a versatile platform for encapsulating pharmaceutically active ingredients.

Career Highlights

Ya-Ling Chiu is affiliated with the Industrial Technology Research Institute, where she continues to innovate and develop new technologies. Her work has garnered attention for its potential impact on the pharmaceutical industry and patient care.

Collaborations

Ya-Ling has collaborated with esteemed colleagues such as Ping-Fu Cheng and Kang-Li Wang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ya-Ling Chiu's contributions to the fields of drug delivery and nucleic acid therapies highlight her role as a leading inventor. Her patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…